Energy & Fat Metabolism Factors
On sale on the US market (according to the DSLD)
ProCaps Laboratories, food supplement from the US market
Energy & Fat Metabolism Factors (ProCaps Laboratories), a food supplement without a usable barcode in DSLD, is described by its US market label. If sold in France, it would be subject to 4 points of French or European regulation, detailed below. Doses of niacine are not compared: their US units depend on the form. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 5 mg a day according to the label (at most 1 serving a day), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- Dose déclarée au-delà d'une limite
Chrome: up to 50 µg a day according to the label (at most 1 serving a day), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
Source: Regulation (EC) No 1925/2006, latest consolidated version, annexe III, partie B (règlement (UE) 2022/2340).
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- ProCaps Laboratories
- Barcode
- Not provided or invalid in DSLD
- Form
- Capsule
- One serving
- 2 capsules
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Gelatin Capsule, Proprietary Protective Methyl B12 Matrix
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Vitamin C | Vitamin | 60 mg |
| Vitamin B1 | Vitamin | 5 mg |
| Vitamin B2 | Vitamin | 5 mg |
| Niacin | Vitamin | 5 mg |
| Vitamin B6 | Vitamin | 5 mg |
| Vitamin B12 | Vitamin | 50 µg |
| Pantothenic Acid | Vitamin | 5 mg |
| Chromium | Mineral | 50 µg |
| Boron Glycinate | Mineral | 300 µg |
| Branched Chain Amino Acid Complex | Blend | 30 mg |
| Leucine | Amino acid | not stated |
| Isoleucine | Amino acid | not stated |
| Valine | Amino acid | not stated |
| L-Lysine Hydrochloride | Amino acid | 50 mg |
| L-Carnitine Tartrate | Other substance | 200 mg |
| Guarana | Plant | 100 mg |
| Green Tea (Camellia sinensis) | Plant | 500 mg |
| Eleuthero (Eleutherococcus senticosus) | Plant | 40 mg |
| Asian Ginseng (Panax ginseng) | Plant | 40 mg |
| Ashwagandha (Withania somnifera) | Plant | 40 mg |
| Rhodiola rosea | Plant | 40 mg |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Energy & Fat Metabolism Factors
Entered into DSLD on 22 November 2024. Withdrawn from the US market on 14 February 2025 (according to the DSLD).- Active ingredient added : Ashwagandha Root Extract (40 mg)
- Active ingredient added : Asian Ginseng Leaf Extract (40 mg)
- Active ingredient added : Boron (100 mcg)
- Active ingredient added : Eleuthero Root Extract (40 mg)
- Active ingredient removed : Ashwagandha (40 mg)
- Active ingredient removed : Asian Ginseng (40 mg)
- Active ingredient removed : Boron Glycinate (300 mcg)
- Active ingredient removed : Eleuthero (40 mg)
- Active ingredient removed : Isoleucine (quantity not stated)
- Active ingredient removed : Leucine (quantity not stated)
- Active ingredient removed : Rhodiola rosea (40 mg)
- Active ingredient removed : Valine (quantity not stated)
- Same quantity, different name: Green Tea Leaf Extract in this version; Green Tea on the displayed label (500 mg)
- Same quantity, different name: Guarana Seed Extract in this version; Guarana on the displayed label (100 mg)
- Same quantity, different name: L-Carnitine in this version; L-Carnitine Tartrate on the displayed label (200 mg)
- Different quantity per serving : Pantothenic Acid: 20 mg in this version; 5 mg on the displayed label
Official label: Energy & Fat Metabolism Factors
Entered into DSLD on 24 October 2022. Withdrawn from the US market on 13 December 2023 (according to the DSLD).- Active ingredient added : Ashwagandha Root Extract (40 mg)
- Active ingredient added : Asian Ginseng Leaf Extract (40 mg)
- Active ingredient added : Boron (100 mcg)
- Active ingredient added : Eleuthero Root Extract (40 mg)
- Active ingredient removed : Ashwagandha (40 mg)
- Active ingredient removed : Asian Ginseng (40 mg)
- Active ingredient removed : Boron Glycinate (300 mcg)
- Active ingredient removed : Eleuthero (40 mg)
- Active ingredient removed : Rhodiola rosea (40 mg)
- Same quantity, different name: Green Tea Leaf Extract in this version; Green Tea on the displayed label (500 mg)
- Same quantity, different name: Guarana Seed Extract in this version; Guarana on the displayed label (100 mg)
- Same quantity, different name: L-Carnitine in this version; L-Carnitine Tartrate on the displayed label (200 mg)
- Different quantity per serving : Pantothenic Acid: 20 mg in this version; 5 mg on the displayed label
Official label: Energy & Fat Metabolism Factors
Entered into DSLD on 22 May 2021. Withdrawn from the US market on 4 February 2022 (according to the DSLD).- Active ingredient added : Ashwagandha extract (40 mg)
- Active ingredient added : Asian Ginseng (Panax ginseng) extract (40 mg)
- Active ingredient added : Eleuthero extract (40 mg)
- Active ingredient removed : Ashwagandha (40 mg)
- Active ingredient removed : Asian Ginseng (40 mg)
- Active ingredient removed : Eleuthero (40 mg)
- Active ingredient removed : Rhodiola rosea (40 mg)
- Same quantity, different name: Green Tea extract in this version; Green Tea on the displayed label (500 mg)
- Same quantity, different name: Guarana extract in this version; Guarana on the displayed label (100 mg)
- Same quantity, different name: L-Carnitine in this version; L-Carnitine Tartrate on the displayed label (200 mg)
- Different quantity per serving : Boron Glycinate: 100 mcg in this version; 300 mcg on the displayed label
- Different quantity per serving : Pantothenic Acid: 20 mg in this version; 5 mg on the displayed label
Official label: Energy & Fat Metabolism Factors
Entered into DSLD on 22 May 2020. Withdrawn from the US market on 19 March 2021 (according to the DSLD).- Active ingredient added : Ashwagandha extract (40 mg)
- Active ingredient added : Asian Ginseng (Panax ginseng) extract (40 mg)
- Active ingredient added : Eleuthero extract (40 mg)
- Active ingredient removed : Ashwagandha (40 mg)
- Active ingredient removed : Asian Ginseng (40 mg)
- Active ingredient removed : Eleuthero (40 mg)
- Active ingredient removed : Rhodiola rosea (40 mg)
- Same quantity, different name: Green Tea extract in this version; Green Tea on the displayed label (500 mg)
- Same quantity, different name: Guarana extract in this version; Guarana on the displayed label (100 mg)
- Same quantity, different name: Acetyl-L-Carnitine in this version; L-Carnitine Tartrate on the displayed label (200 mg)
- Different quantity per serving : Boron Glycinate: 100 mcg in this version; 300 mcg on the displayed label
- Different quantity per serving : Pantothenic Acid: 20 mg in this version; 5 mg on the displayed label
Official label: Energy & Fat Metabolism Factors
Entered into DSLD on 24 March 2016. Withdrawn from the US market on 14 February 2025 (according to the DSLD).Same active composition.
Official label: Energy & Fat Metabolism Factors
Entered into DSLD on 24 January 2014. Withdrawn from the US market on 4 February 2022 (according to the DSLD).- Active ingredient added : L-Isoleucine (10 mg)
- Active ingredient added : L-Leucine (20 mg)
- Active ingredient added : L-Valine (10 mg)
- Active ingredient removed : Branched Chain Amino Acid Complex (30 mg)
- Active ingredient removed : Isoleucine (quantity not stated)
- Active ingredient removed : Leucine (quantity not stated)
- Active ingredient removed : Valine (quantity not stated)
- Same quantity, different name: Panax Ginseng in this version; Asian Ginseng on the displayed label (40 mg)
- Same quantity, different name: L-Carnitine Fumarate in this version; L-Carnitine Tartrate on the displayed label (200 mg)
- Different quantity per serving : Green Tea: 300 mg in this version; 500 mg on the displayed label
- Different quantity per serving : Guarana: 300 mg in this version; 100 mg on the displayed label
- Different quantity per serving : L-Lysine Hydrochloride: 100 mg in this version; 50 mg on the displayed label
- Different quantity per serving : Niacin: 10 mg in this version; 5 mg on the displayed label
- Different quantity per serving : Pantothenic Acid: 20 mg in this version; 5 mg on the displayed label
- Different quantity per serving : Vitamin B1: 10 mg in this version; 5 mg on the displayed label
- Different quantity per serving : Vitamin B12: 100 mcg in this version; 50 mcg on the displayed label
- Different quantity per serving : Vitamin B2: 10 mg in this version; 5 mg on the displayed label
- Different quantity per serving : Vitamin B6: 10 mg in this version; 5 mg on the displayed label
Official label: Energy & Fat Metabolism Factors
Entered into DSLD on 25 January 2012. Withdrawn from the US market on 1 January 2012 (according to the DSLD).- Active ingredient added : L-Isoleucine (10 mg)
- Active ingredient added : L-Leucine (20 mg)
- Active ingredient added : L-Valine (10 mg)
- Active ingredient removed : Branched Chain Amino Acid Complex (30 mg)
- Active ingredient removed : Isoleucine (quantity not stated)
- Active ingredient removed : Leucine (quantity not stated)
- Active ingredient removed : Valine (quantity not stated)
- Same quantity, different name: Asian Ginseng, extract in this version; Asian Ginseng on the displayed label (40 mg)
- Same quantity, different name: L-Carnitine Fumarate in this version; L-Carnitine Tartrate on the displayed label (200 mg)
- Different quantity per serving : Green Tea: 300 mg in this version; 500 mg on the displayed label
- Different quantity per serving : Guarana: 300 mg in this version; 100 mg on the displayed label
- Different quantity per serving : L-Lysine Hydrochloride: 100 mg in this version; 50 mg on the displayed label
- Different quantity per serving : Niacin: 10 mg in this version; 5 mg on the displayed label
- Different quantity per serving : Pantothenic Acid: 20 mg in this version; 5 mg on the displayed label
- Different quantity per serving : Vitamin B1: 10 mg in this version; 5 mg on the displayed label
- Different quantity per serving : Vitamin B12: 100 mcg in this version; 50 mcg on the displayed label
- Different quantity per serving : Vitamin B2: 10 mg in this version; 5 mg on the displayed label
- Different quantity per serving : Vitamin B6: 10 mg in this version; 5 mg on the displayed label
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Eleuthero
Read the warning, when it applies and the studies cited
ELEUTHERO - ELEUTHEROCOCCUS SENTICOSUS
Route of administration: Oral (ESCOP 2003; Bradley 1992)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Barnes et al. 2007; ESCOP 2003).
Sources cited by Health Canada (2)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an acute infection (Brinker 2010; Mills and Bone 2000).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone; 2000.
Contraindications
Do not use if you have high blood pressure (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000; Mills and Bone 2000).
Sources cited by Health Canada (5)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): The Pharmaceutical Press; 2007.
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.
- Mills S, Bone K. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone; 2000.
- Asian Ginseng
Read the warning, when it applies and the studies cited
PANAX GINSENG
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Vuksan et al. 2008; Seely et al. 2008; Sievenpiper et al. 2006; ESCOP 2003; Tetsutani et al. 2000; Sotaniemi et al. 1995; Chin 1991).
Sources cited by Health Canada (8)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Chin RKH. Ginseng and common pregnancy disorders. Asia-Oceania Journal of Obstetrics and Gynaecology 1991;17(4):379-380. PubMed
- ESCOP 2003: European Scientific Cooperative on Phytotherapy Scientific Committee. ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Seely D, Dugoua JJ, Perri D, Mills E, Koren G. Safety and efficacy of Panax ginseng during pregnancy and lactation. The Canadian Journal of Clinical Pharmacology 2008;15(1):e87-e94.
- Sievenpiper JL, Sung MK, Buono MD, Seung-Lee K, Nam KY, Arnason JT, Leiter LA, Vuksan V. Korean red ginseng rootlets decrease acute postprandial glycemia: results from sequential preparation- and dose-finding studies. Journal of the American College of Nutrition 2006;25(2):100-107. PubMed Randomised trial
- Sotaniemi EA, Haapakoski E, Rautio A. Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care 1995;18(10):1373-1375. PubMed Clinical trial
- Tetsutani T, Yamamura M, Yamaguchi T, Onoyama O, Kono M. Can red ginseng control blood glucose in diabetic patients. The Ginseng Review 2000;28:44-47.
- Vuksan V, Sung MK, Sievenpiper JL, Stavro PM, Jenkins AL, Buono MD, Lee KS, Leiter LA, Nam KY, Arnason JT, Choi M, Naeem A. Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety. Nutrition, Metabolism & Cardiovascular Diseases 2008;18(1):46-56. PubMed Randomised trial
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking antidepressant medication, blood thinners or digoxin (Brinker 2010; Lee et al. 2008a; Dasgupta and Reyes 2005; Janetzki and Morreale 1997; Gonzalez-Seijo et al. 1995; Shader and Greenblatt 1988; Jones and Runikis 1987; Shader and Greenblatt 1985).
Sources cited by Health Canada (8)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Dasgupta A, Reyes MA. Effect of Brazillian, Indian, Siberian, Asian, and North American ginseng on serum digoxin measurement by immunoassays and binding of digoxin-like immunoreactive components of ginseng with Fab Fragment of antidigoxin antibody (Digiband). American Journal of Clinical Pathology 2005;124(2):229-236. PubMed
- Gonzalez-Seijo JC, Ramos YM, Lastra I. Manic episode and ginseng: report of a possible case. Journal of Clinical Psychopharmacology 1995;15(6):447-448. PubMed Case report
- Janetzki K, Morreale AP. Probable interaction between warfarin and ginseng. American Journal of Health-System Pharmacy 1997;54(6):692-693.
- Jones BD, Runikis AM. Interaction of ginseng with phenelzine. Journal of Clinical Pharmacology 1987;7(3):201-202. PubMed Case report
- Lee SH, Ahn YM, Ahn SY, Doo HK, Lee BC. Interaction between warfarin and Panax ginseng in ischemic stroke patients. The Journal of Alternative and Complementary Medicine 2008a;14(6):715-721. PubMed Randomised trial
- Shader RI, Greenblatt DJ. Bees, ginseng and MAOIs revisited. Journal of Clinical Psychopharmacology 1988;8(4):235. PubMed Case report
- Shader RI, Greenblatt DJ. Phenelzine and the dream machine – ramblings and reflections. Journal of Clinical Psychopharmacology 1985;5(2):65. PubMed Case report
Contraindications
Condition of application: Traditional Chinese Medicine.
Do not use in cases of yin deficiency with heat signs, heat excess, or in the absence of significant qi deficiency (Bensky et al. 2004).
Sources cited by Health Canada (1)
- Bensky D, Clavey, Stöger E, Gamble A. Chinese Herbal Medicine: Materia Medica. 3rd edition. Seattle (WA): Eastland Press, Incorporated; 2004.
Known adverse reactions
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience insomnia, anxiety or headaches (Lee et al. 2008b; Vuksan et al 2008; de Andrade et al.2007; Sievenpiper et al. 2006; Coon and Ernst 2002; Ellis and Reddy 2002; Scaglione et al. 2001; Siegel 1979).
Sources cited by Health Canada (8)
- Coon JT, Ernst E. Panax ginseng: a systematic review of adverse effects and drug interactions. Drug Safety 2002;25(5):323-344. PubMed Systematic review
- de Andrade E, de Masquita AA, de Almeida Claro J, de Andrade PM, Ortiz V, Paranhos M, Srougi M. Study of the efficacy of Korean Red Ginseng in the treatment of erectile dysfunction. Asian Journal of Andrology 2007;9(2):241-244.
- Ellis JM, Reddy P. Effects of Panax ginseng on quality of life. The Annals of Pharmacotherapy 2002;36(3):375-379. PubMed Randomised trial
- Lee ST, Chu K, Sim JY, Heo JH, Kim M. Panax ginseng enhances cognitive performance in Alzheimer disease. Alzheimer Disease and Associated Disorders 2008b;22(3):222-226. PubMed Randomised trial
- Scaglione F, Weiser K, Alessandria M. Effects of the standardised ginseng extract G115 in patients with chronic bronchitis. Clinical Drug Investigation 2001;21(1):41-45.
- Siegel RK. Ginseng abuse syndrome. Problems with the panacea. The Journal of the American Medical Association 1979;241(15):1614-1615. PubMed
- Sievenpiper JL, Sung MK, Buono MD, Seung-Lee K, Nam KY, Arnason JT, Leiter LA, Vuksan V. Korean red ginseng rootlets decrease acute postprandial glycemia: results from sequential preparation- and dose-finding studies. Journal of the American College of Nutrition 2006;25(2):100-107. PubMed Randomised trial
- Vuksan V, Sung MK, Sievenpiper JL, Stavro PM, Jenkins AL, Buono MD, Lee KS, Leiter LA, Nam KY, Arnason JT, Choi M, Naeem A. Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety. Nutrition, Metabolism & Cardiovascular Diseases 2008;18(1):46-56. PubMed Randomised trial
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
- Ashwagandha
Read the warning, when it applies and the studies cited
ASHWAGANDHA - WITHANIA SOMNIFERA
Route of administration: Oral
Cautions and warnings
Condition of application: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).
Sources cited by Health Canada (3)
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press, LLC; 1997.
- Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Ashwagandha Root (Withania somnifera) - Standards of Analysis, Quality Control, and Therapeutics. Santa Cruz (CA): American Herbal Pharmacopoeia; 2000.
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze K, éditeurs. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13e édition. Washington (DC) : American Pharmaceutical Association; 2002.
When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).
Sources cited by Health Canada (3)
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA and Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
- McGuffin M, Hobbs C, Upton R, Goldberg A, éditeurs. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL) : CRC Press, LLC; 1997.
- Upton R, éditeur. Ashwagandha Root, Withania somnifera Analytical, Quality Control, And Therapeutic Monograph. Santa Cruz (CA) : American Herbal Pharmacopoeia and Therapeutic Compendium; 2000.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : ProCaps Laboratories
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Energy & Fat Metabolism Factors (ProCaps Laboratories): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/dsld-179104-energy-fat-metabolism-factors-procaps-laboratories, updated 25 July 2018.